Related Experiment Videos
Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator
1Department of Internal Medicine, VA Medical Center, Iowa City, Iowa.
American Journal of Respiratory Cell and Molecular Biology
|January 1, 1995
Summary
This study reveals that formylmethionylleucylphenylalanine (FMLP), leukotriene B4 (LTB4), and platelet-activating factor (PAF) are potent chemoattractants for eosinophils. Their efficacy varies across different barriers, impacting lung inflammation.
Area of Science:
- Immunology
- Cell Biology
Background:
- Eosinophils are key immune cells in allergic responses and inflammatory lung diseases.
- Bacterial products and inflammatory mediators can trigger eosinophil accumulation in the respiratory tract.
Purpose of the Study:
- To compare the eosinophil chemoattractant abilities of formylmethionylleucylphenylalanine (FMLP), leukotriene B4 (LTB4), and platelet-activating factor (PAF).
- To investigate eosinophil migration across different barriers: naked filters, human umbilical vein endothelial cells (HUVEC), and A549 epithelial cells.
Main Methods:
- Eosinophil migration assays were performed across 3.0-microns-pore naked filters and cell monolayers.
- Kinetic experiments tracked migration over time (60 min to 2 h).
- Dose-response relationships for each chemoattractant were evaluated.
Main Results:
- All three chemoattractants (FMLP, LTB4, PAF) induced dose-responsive eosinophil migration across all tested barriers.
- Eosinophil migration peaked by 2 hours.
- The rank order of potency differed between naked filters (FMLP > PAF ≥ LTB4) and cellular barriers (FMLP > LTB4 > PAF).
Conclusions:
- FMLP, LTB4, and PAF are significant chemoattractants for both eosinophils and neutrophils.
- These agents likely mediate granulocytic inflammatory responses in the lung.
- The differential potency across barriers suggests specific roles in lung inflammation dynamics.